TKI (Tyrosine Kinase Inhibitor)

A Tyrosine Kinase Inhibitor (TKI) is a targeted cancer medication that blocks specific enzymes called tyrosine kinases, which are involved in the growth and division of cancer cells. By inhibiting these enzymes, TKIs can slow or stop the progression of certain cancers, such as lung or chronic myeloid leukemia. They are designed to interfere with abnormal signals that make cancer cells multiply uncontrollably, while often sparing normal cells. TKIs are taken orally and represent a precise approach in cancer therapy, aiming to reduce side effects compared to traditional chemotherapy.